Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 10
Results: 8
Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 807, doi. 10.1007/s40261-022-01200-3
- By:
- Publication type:
- Article
Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 799, doi. 10.1007/s40261-022-01195-x
- By:
- Publication type:
- Article
AVT02: An Adalimumab Biosimilar.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 875, doi. 10.1007/s40261-022-01196-w
- By:
- Publication type:
- Article
Evaluation of the Effect of Uridine Diphosphate-Glucuronosyltransferases (UGT) Inhibition by Valproic Acid on Vixotrigine Pharmacokinetics in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 829, doi. 10.1007/s40261-022-01194-y
- By:
- Publication type:
- Article
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 865, doi. 10.1007/s40261-022-01193-z
- By:
- Publication type:
- Article
Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 813, doi. 10.1007/s40261-022-01191-1
- By:
- Publication type:
- Article
Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 853, doi. 10.1007/s40261-022-01192-0
- By:
- Publication type:
- Article
Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 10, p. 839, doi. 10.1007/s40261-022-01188-w
- By:
- Publication type:
- Article